|
| 36929923 | Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles. | Rheumatology (Oxford) | 2023 |
| 37562873 | Neuromuscular pathology. | Handb Clin Neurol | 2023 |
| 37123986 | Parent-of-Origin Effect on the Age at Symptom Onset in Myotonic Dystrophy Type 2. | Neurol Genet | 2023 |
| 37001556 | Neuromuscular Complications of COVID-19: Evidence from the Third Year of the Global Pandemic. | Semin Neurol | 2023 |
| 36790141 | Frequency and type of cancers in myotonic dystrophy: A retrospective cross-sectional study. | Muscle Nerve | 2023 |
| 36923454 | Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial. | Lancet Rheumatol | 2023 |
| 34857535 | Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study. | Neurology | 2022 |
| 35500790 | 2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders. | Heart Rhythm | 2022 |
| 35428982 | Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy. | Muscle Nerve | 2022 |
| 35696196 | Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults. | JAMA Neurol | 2022 |
| 35684980 | Safety and outcomes of eculizumab for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice. | Muscle Nerve | 2022 |
| 37006658 | Retinal Vasculitis in a Patient With Isaacs Syndrome and Inclusion Body Myositis. | J Vitreoretin Dis | 2022 |
| 36409344 | Pseudoacute Presentation of Inclusion Body Myositis After COVID-19 Infection. | J Clin Neuromuscul Dis | 2022 |
| 36198183 | Intravenous Immune Globulin Therapy in Dermatomyositis. | N Engl J Med | 2022 |
| 33208546 | Clinical Reasoning: A 63-Year-Old Woman Presenting With Bilateral Leg Pain. | Neurology | 2021 |
| 33597289 | Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. | Neurology | 2021 |
| 33824169 | Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality. | Neurology | 2021 |
| 34378210 | Retrospective analysis of safety and outcomes of rituximab for myasthenia gravis in patients â¿¥65Â years old. | Muscle Nerve | 2021 |
| 34697214 | Author Response: Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial. | Neurology | 2021 |
| 34725253 | Author Response: Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19. | Neurology | 2021 |
| 34656144 | A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A. | Orphanet J Rare Dis | 2021 |
| 34155186 | Neuromuscular complications of coronavirus disease-19. | Curr Opin Neurol | 2021 |
| 34099523 | Skeletal Muscle and Peripheral Nerve Histopathology in COVID-19. | Neurology | 2021 |
| 34281989 | Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. | J Immunother Cancer | 2021 |
| 32202612 | Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials. | JAMA Neurol | 2020 |
| 33216474 | Covid-19-Associated Myopathy Caused by Type I Interferonopathy. | N Engl J Med | 2020 |
| 32690797 | Long-term safety and tolerability of bimagrumab (BYM338) in sporadic inclusion body myositis. | Neurology | 2020 |
| 32611638 | Minimal manifestation status and prednisone withdrawal in the MGTX trial. | Neurology | 2020 |
| 32284362 | COVID-19 and neuromuscular disorders. | Neurology | 2020 |
| 32271162 | Congenital myasthenic syndrome-associated agrin variants affect clustering of acetylcholine receptors in a domain-specific manner. | JCI Insight | 2020 |
| 31107564 | Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis. | Muscle Nerve | 2019 |
| 30216244 | Median Nerve Ultrasonography Measurements Correlate With Electrodiagnostic Carpal Tunnel Syndrome Severity. | J Am Acad Orthop Surg | 2019 |
| 31358616 | Idiopathic inflammatory myopathy: Interrater variability in muscle biopsy reading. | Neurology | 2019 |
| 31326977 | Highly differentiated cytotoxic T cells in inclusion body myositis. | Brain | 2019 |
| 31405908 | Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies. | Neurology | 2019 |
| 31397289 | Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. | Lancet Neurol | 2019 |
| 30948559 | Proximal muscle weakness. | Pract Neurol | 2019 |
| 29293942 | Atypical Skeletal Muscle Profiles in Human Immunodeficiency Virus-Infected Asymptomatic Middle-Aged Adults. | Clin Infect Dis | 2018 |
| 30341597 | Autoimmune Myopathies: Updates on Evaluation and Treatment. | Neurotherapeutics | 2018 |
| 29643082 | Updating <i>Neurology</i>® authorship criteria: Ensuring inclusion of those making valuable intellectual contributions. | Neurology | 2018 |
| 29358511 | Clinical Reasoning: A 60-year-old man with arm weakness and numbness. | Neurology | 2018 |
| 27708273 | The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States. | J Hum Genet | 2017 |
| 28385805 | 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. | Ann Rheum Dis | 2017 |
| 28382787 | 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. | Arthritis Rheumatol | 2017 |
| 29106061 | 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. | Arthritis Rheumatol | 2017 |
| 29177080 | EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. | RMD Open | 2017 |
| 29079590 | 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. | Ann Rheum Dis | 2017 |
| 28977549 | 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects. | Rheumatology (Oxford) | 2017 |
| 27074086 | INTERACTIVE MEDICAL CASE. Eye of the Beholder. | N Engl J Med | 2016 |
| 26662952 | Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine. | Muscle Nerve | 2016 |